Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAI and Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
NCT00004146Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2000
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carboxyamidotriazole in glioblastoma multiforme (GBM), giant cell glioblastoma (GC-GBM), Gliosarcoma (GS), sponsored by National Cancer Institute. Started Mar 2000; status: completed.
02
Drugs
carboxyamidotriazole
03
Conditions
glioblastoma multiforme (GBM)giant cell glioblastoma (GC-GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00004146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004146.